Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies
Sushant Patkar(National Institutes of Health), Thomas Ried(National Institutes of Health), Michael J. Difilippantonio(National Cancer Institute), Jochen Gaedcke(Universitätsmedizin Göttingen), Annette Lischka(Universitätsklinikum Aachen), Jordi Camps(Centro de Investigación Biomédica en Red), Jens K. Habermann(University Hospital Schleswig-Holstein), Daniel Bronder(National Cancer Institute), Marian Grade(Universitätsmedizin Göttingen), Daniela Hirsch(OTH Regensburg), Danny Wangsa(National Cancer Institute), Yuri Lazebnik(Stony Brook University), Rüdiger Braun(University Hospital Schleswig-Holstein), Eytan Ruppin(Cedars-Sinai Medical Center), Gert Auer(Karolinska Institutet), Kerstin Heselmeyer‐Haddad(National Cancer Institute), Rachel Lokanga(National Cancer Institute), Darawalee Wangsa(National Cancer Institute), Cristina Montagna(Rutgers, The State University of New Jersey), Markus Brown(National Cancer Institute), Yue Hu(National Cancer Institute), Noam Auslander(National Center for Biotechnology Information), Β. Michael Ghadimi(Universitätsmedizin Göttingen), Wei-Dong Chen(National Cancer Institute), Georg Emons(Universitätsmedizin Göttingen)
Cited by 29
Related Papers
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
Caspase-9 and APAF-1 form an active holoenzyme
|Genes & Development|1999|564